Echocardiography in Marfan Syndrome

Introduction to Echocardiography

The American College of Cardiology recommends an echocardiogram as the investigation of choice to rule out life-threatening cardiovascular complications in Marfan syndrome, specifically aortic root dilatation and dissection, which are the primary causes of mortality in this condition 1, 2
The American Heart Association emphasizes that aortic root dilatation leading to dissection and rupture is the most life-threatening complication in Marfan syndrome, accounting for the majority of morbidity and mortality in these patients 1, 3

The ACC/AHA/AATS guidelines provide the strongest evidence that an echocardiogram is mandatory at the time of Marfan syndrome diagnosis to determine baseline aortic root and ascending aortic diameters, with repeat imaging at 6 months to establish the rate of enlargement 1, 2
Annual echocardiographic surveillance is required for patients with stable aortic dimensions to monitor for progressive dilatation, according to the American College of Cardiology 1, 2
More frequent imaging (every 6 months) is indicated when the maximal aortic diameter reaches 4.5 cm or greater, or if significant growth from baseline is documented, as recommended by the American Heart Association 1, 2

Transthoracic echocardiography (TTE) accurately visualizes the aortic root, which is the primary site of pathology in Marfan syndrome, making it the ideal screening and surveillance tool, according to the European Society of Cardiology 1, 2
The American College of Medical Genetics emphasizes that echocardiography is an essential test whenever Marfan syndrome is considered seriously, particularly when concerns about life-threatening complications and physical activity restrictions are raised 4, 5, 6, 7

At diagnosis, perform baseline echocardiogram to measure aortic root diameter at the annulus, sinuses of Valsalva, sinotubular junction, and ascending aorta, as recommended by the American College of Cardiology 1, 2, 8
Ongoing surveillance includes annual echocardiogram if aortic root <4.5 cm and growth rate <0.5 cm/year, and every 6 months if diameter ≥4.5 cm or growth rate ≥0.5 cm/year, according to the American Heart Association 1, 2, 8
Consider surgical repair when diameter reaches 5.0-5.5 cm, or 4.0 cm in women contemplating pregnancy, as recommended by the American College of Cardiology 1, 8

Virtually every patient with Marfan syndrome develops aortic disease at some point during their lifetime, making cardiovascular assessment the highest priority, according to the American Heart Association 9, 10

The European Society of Cardiology recommends that an echocardiogram should measure specific anatomical points, including left ventricular function, aortic valve and aortic regurgitation, mitral valve prolapse and regurgitation, and tricuspid valve abnormalities 11
The American College of Cardiology suggests that mitral valve prolapse and regurgitation should be evaluated by echocardiography in patients with Marfan syndrome 9, 11

The American Heart Association recommends that MRI is reserved for specific situations, such as Loeys-Dietz syndrome, which requires yearly MRI from cerebrovascular circulation to pelvis 9, 10, 12
The European Society of Cardiology states that echocardiography is the first-line test, while MRI or CT should be performed in every Marfan patient eventually 11
The American College of Radiology notes that CT provides external diameter measurements and is useful for surgical planning, but involves radiation exposure and is not recommended as the initial diagnostic test 9